BACKGROUND: Proinflammatory cytokines stimulate osteoclast activity and this could lead to increased bone resorption in patients with cystic fibrosis. The aim of this study was to determine whether markers of systemic inflammation are related to changes in bone mineral content (BMC) in adults with cystic fibrosis. METHODS: Total body BMC was assessed by dual energy x ray absorptiometry in 100 patients (54 male) of mean (SD) age 25.6 (7.1) years and forced expiratory volume in 1 second (FEV(1)) 61.8 (24.1)% predicted on recruitment to the study and 1 year later. Blood was also taken at these time points to measure markers of systemic inflammation. RESULTS: After 1 year BMC had reduced by 16.1 (62.1) g, p = 0.01; (0.6 (2.8)%). The change in BMC was related to mean levels of interleukin (IL)-6 (r(s) = -0.39, p<0.001) and C reactive protein (r(s) = -0.34, p = 0.002), intravenous antibiotic use (r(s) = -0.27, p = 0.006) and oral corticosteroid use (r(s) = -0.20, p = 0.045). Urinary markers of osteoclast activity were also related to IL-6 (r(s) = 0.27, p = 0.02). Multiple linear regression revealed that IL-6 (coefficient -2.2 (95% CI -3.4 to -1.0) per pg/ml, p = 0.001), colonisation with Burkholderia cepacia (coefficient -46.8 (95% CI -75.5 to -18.1), p = 0.002), and annual change in BMI (coefficient 15.4 (95% CI 3.6 to 27.2) per kg/m(2), p = 0.011) were independently significant predictors of annual change in BMC. CONCLUSIONS: These data suggest a pathophysiological mechanism by which chronic pulmonary infection results in bone loss in patients with cystic fibrosis.
BACKGROUND: Proinflammatory cytokines stimulate osteoclast activity and this could lead to increased bone resorption in patients with cystic fibrosis. The aim of this study was to determine whether markers of systemic inflammation are related to changes in bone mineral content (BMC) in adults with cystic fibrosis. METHODS: Total body BMC was assessed by dual energy x ray absorptiometry in 100 patients (54 male) of mean (SD) age 25.6 (7.1) years and forced expiratory volume in 1 second (FEV(1)) 61.8 (24.1)% predicted on recruitment to the study and 1 year later. Blood was also taken at these time points to measure markers of systemic inflammation. RESULTS: After 1 year BMC had reduced by 16.1 (62.1) g, p = 0.01; (0.6 (2.8)%). The change in BMC was related to mean levels of interleukin (IL)-6 (r(s) = -0.39, p<0.001) and C reactive protein (r(s) = -0.34, p = 0.002), intravenous antibiotic use (r(s) = -0.27, p = 0.006) and oral corticosteroid use (r(s) = -0.20, p = 0.045). Urinary markers of osteoclast activity were also related to IL-6 (r(s) = 0.27, p = 0.02). Multiple linear regression revealed that IL-6 (coefficient -2.2 (95% CI -3.4 to -1.0) per pg/ml, p = 0.001), colonisation with Burkholderia cepacia (coefficient -46.8 (95% CI -75.5 to -18.1), p = 0.002), and annual change in BMI (coefficient 15.4 (95% CI 3.6 to 27.2) per kg/m(2), p = 0.011) were independently significant predictors of annual change in BMC. CONCLUSIONS: These data suggest a pathophysiological mechanism by which chronic pulmonary infection results in bone loss in patients with cystic fibrosis.
Authors: S Kotake; K Sato; K J Kim; N Takahashi; N Udagawa; I Nakamura; A Yamaguchi; T Kishimoto; T Suda; S Kashiwazaki Journal: J Bone Miner Res Date: 1996-01 Impact factor: 6.741
Authors: G D Roodman; N Kurihara; Y Ohsaki; A Kukita; D Hosking; A Demulder; J F Smith; F R Singer Journal: J Clin Invest Date: 1992-01 Impact factor: 14.808
Authors: C S Haworth; P L Selby; A K Webb; M E Dodd; H Musson; R McL Niven; G Economou; A W Horrocks; A J Freemont; E B Mawer; J E Adams Journal: Thorax Date: 1999-11 Impact factor: 9.139
Authors: R M Aris; A R Stephens; D A Ontjes; A Denene Blackwood; R K Lark; M B Hensler; I P Neuringer; G E Lester Journal: Am J Respir Crit Care Med Date: 2000-11 Impact factor: 21.405
Authors: T L Bonfield; J R Panuska; M W Konstan; K A Hilliard; J B Hilliard; H Ghnaim; M Berger Journal: Am J Respir Crit Care Med Date: 1995-12 Impact factor: 21.405
Authors: Troy D Pashuck; Sarah E Franz; Molly K Altman; Clive H Wasserfall; Mark A Atkinson; Thomas J Wronski; Terence R Flotte; Michael S Stalvey Journal: Pediatr Res Date: 2009-03 Impact factor: 3.756
Authors: Catherine M Gordon; Ellen J Anderson; Karen Herlyn; Jane L Hubbard; Angela Pizzo; Rondi Gelbard; Allen Lapey; Peter A Merkel Journal: J Am Diet Assoc Date: 2007-12
Authors: Alexandra Papaioannou; Courtney C Kennedy; Andreas Freitag; George Ioannidis; John O'Neill; Colin Webber; Margaret Pui; Yves Berthiaume; Harvey R Rabin; Nigel Paterson; Alphonse Jeanneret; Elias Matouk; Josee Villeneuve; Madeline Nixon; Jonathan D Adachi Journal: Chest Date: 2008-07-18 Impact factor: 9.410
Authors: David A Ngan; Pearce G Wilcox; May Aldaabil; Yuexin Li; Jonathon A Leipsic; Don D Sin; S F Paul Man Journal: BMC Pulm Med Date: 2012-02-14 Impact factor: 3.317
Authors: Alexandra Papaioannou; Courtney C Kennedy; Andreas Freitag; John O'Neill; Margaret Pui; George Ioannidis; Colin Webber; Anjali Pathak; Suzanne Hansen; Rosamund Hennessey; Jonathan D Adachi Journal: BMC Musculoskelet Disord Date: 2008-09-19 Impact factor: 2.362
Authors: A Papaioannou; C C Kennedy; G Ioannidis; A Sawka; W M Hopman; L Pickard; J P Brown; R G Josse; S Kaiser; T Anastassiades; D Goltzman; M Papadimitropoulos; A Tenenhouse; J C Prior; W P Olszynski; J D Adachi Journal: Osteoporos Int Date: 2008-09-19 Impact factor: 4.507